⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FHTX News
Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
globenewswire.com
FHTX
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
globenewswire.com
FHTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
prnewswire.com
FHTX